UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment

Journal of the American Society of Nephrology, 2020-03, Vol.31 (3), p.456-468

2020

Volltextzugriff (PDF)

Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease

Kidney international, 2013-06, Vol.83 (6), p.1029-1041

2013

Volltextzugriff (PDF)

A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY)

Journal of the American Society of Nephrology, 2021-06, Vol.32 (6), p.1465-1473

2021

Volltextzugriff (PDF)

Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study

Hypertension (Dallas, Tex. 1979), 2021-07, Vol.78 (1), p.HYPERTENSIONAHA12117073-81

2021

Volltextzugriff (PDF)

Phosphate Frustration: Treatment Options to Complement Current Therapies

International journal of nephrology, 2022-08, Vol.2022, p.9457440-9

2022

Volltextzugriff (PDF)

Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Journal of the American Society of Nephrology, 2021-01, Vol.32 (1), p.211-222

2021

Volltextzugriff (PDF)

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

American journal of nephrology, 2018-01, Vol.47 (1), p.40-47

2018

Volltextzugriff (PDF)

A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5

American journal of kidney diseases, 2015-05, Vol.65 (5), p.728-736

2015

Volltextzugriff (PDF)

Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease

PloS one, 2017-11, Vol.12 (11), p.e0188712-e0188712

2017

Volltextzugriff (PDF)

Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial

Hypertension (Dallas, Tex. 1979), 2016-01, Vol.67 (1), p.63-69

2016

Volltextzugriff (PDF)

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial

Journal of the American Society of Nephrology, 2021-11, Vol.32 (11), p.2731-2734

2021

Volltextzugriff (PDF)

Clinical outcomes associated with the use of the NexSite hemodialysis catheter with new exit barrier technology: Results from a prospective, observational multi-center registry study

PloS one, 2019-10, Vol.14 (10), p.e0223285-e0223285

2019

Volltextzugriff (PDF)

Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD

Clinical and translational science, 2021-01, Vol.14 (1), p.299-309

2021

Volltextzugriff (PDF)

Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease

Kidney international, 2016-11, Vol.90 (5), p.1115-1122

2016

Volltextzugriff (PDF)

Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension

American journal of kidney diseases, 2021-12, Vol.78 (6), p.846-856.e1

2021

Volltextzugriff (PDF)

Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia

Journal of the American Society of Nephrology, 2017-06, Vol.28 (6), p.1851-1858

2017

Volltextzugriff (PDF)

Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study

Journal of the American Society of Nephrology, 2021-03, Vol.32 (3), p.737-755

2021

Volltextzugriff (PDF)

Effects of Selonsertib in Patients with Diabetic Kidney Disease

Journal of the American Society of Nephrology, 2019-10, Vol.30 (10), p.1980-1990

2019

Volltextzugriff (PDF)

Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial

Journal of the American Heart Association, 2019-02, Vol.8 (3), p.e010091

2019

Volltextzugriff (PDF)

Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease

Clinical pharmacology and therapeutics, 2024-10, Vol.116 (4), p.1052-1061

2024

Volltextzugriff (PDF)

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study

Clinical journal of the American Society of Nephrology, 2019-06, Vol.14 (6), p.798-809

2019

Volltextzugriff (PDF)

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

The New England journal of medicine, 2011-07, Vol.365 (4), p.327-336

2011

Volltextzugriff (PDF)

A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease

American journal of nephrology, 2017-01, Vol.46 (5), p.364-370

2017

Volltextzugriff (PDF)

Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease

Advances in chronic kidney disease, 2019-07, Vol.26 (4), p.272-291

2019

Volltextzugriff (PDF)

Patterns of blood pressure response during intensive BP lowering and clinical events: results from the secondary prevention of small subcortical strokes trial

Blood pressure, 2018-03, Vol.27 (2), p.73-81

2018

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(128)

Publikationsform

Artikel
(145)
Tagungsberichte
(1)

Sprache

Englisch
(146)

Erscheinungsjahr

n.n

Thema

Science & Technology
(90)
Life Sciences & Biomedicine
(87)
Humans
(68)
Male
(54)
Female
(49)
Urology & Nephrology
(45)
Middle Aged
(44)
Aged
(40)
Adult
(24)
Biological And Medical Sciences
(21)
Kidney Diseases
(20)
Cardiovascular System & Cardiology
(19)
Renal Insufficiency, Chronic - Complications
(19)
Anemia
(18)
Treatment Outcome
(17)
Anemia - Drug Therapy
(16)
Chronic Kidney Disease
(16)
Hemodialysis
(16)
Double-Blind Method
(15)
Blood Pressure
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment

Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease

A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY)

Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study

Phosphate Frustration: Treatment Options to Complement Current Therapies

Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5

Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease

Achieved Blood Pressure and Outcomes in the Secondary Prevention of Small Subcortical Strokes Trial

Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial

Clinical outcomes associated with the use of the NexSite hemodialysis catheter with new exit barrier technology: Results from a prospective, observational multi-center registry study

Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD

Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease

Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension

Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia

Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study

Effects of Selonsertib in Patients with Diabetic Kidney Disease

Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial

Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study

Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease

Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease

Patterns of blood pressure response during intensive BP lowering and clinical events: results from the secondary prevention of small subcortical strokes trial

Suchergebnisse filtern